65
https://pubmed.ncbi.nlm.nih.gov/38095250
The abstract reports on the current state of therapy for Crohn’s disease, including both conventional and advanced treatments such as tumor necrosis factor inhibitors, interleukin-12/23 inhibitors, integrin inhibitors, and Janus kinase-1 inhibitors, but notes that the disease remains incurable and that not all patients respond to treatment.